News

Pharmabiz1h
AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis
AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis: San Diego Thursday, June 5, 2025, 18:00 Hrs [IST] AnaptysBio, Inc., a clinic ...
Pharmabiz4h
MarkHerz inks MoU with Technical University of Munich Hospital to develop cardiovascular and diabetes-targeted AAV gene therapies
MarkHerz inks MoU with Technical University of Munich Hospital to develop cardiovascular and diabetes-targeted AAV gene therapies: Munich Thursday, June 5, 2025, 15:00 Hrs [IST] M ...
Pharmabiz3h
Alto Neuroscience enters into an asset purchase agreement with Chase Therapeutics Corporation
Alto Neuroscience enters into an asset purchase agreement with Chase Therapeutics Corporation: Mountain View, Califfornia Thursday, June 5, 2025, 16:00 Hrs [IST] Alto Neuroscience ...
Pharmabiz4h
Alvotech and Dr. Reddy’s collaborate to co-develop oncology biosimilar candidate
Alvotech and Dr. Reddy’s collaborate to co-develop oncology biosimilar candidate: Our Bureau, Bengaluru Thursday, June 5, 2025, 14:30 Hrs [IST] Alvotech a global biotech company ...
Pharmabiz5h
QuidelOrtho announces strategy to speed up growth in molecular diagnostics
QuidelOrtho announces strategy to speed up growth in molecular diagnostics: San Diego Thursday, June 5, 2025, 14:00 Hrs [IST] QuidelOrtho Corporation, a global provider of innovat ...
Pharmabiz6h
Bayer blockbuster Nubeqa receives US FDA approval for patients with advanced prostate cancer
Bayer blockbuster Nubeqa receives US FDA approval for patients with advanced prostate cancer: Berlin Thursday, June 5, 2025, 13:00 Hrs [IST] Bayer announced that the US Food and D ...
Pharmabiz7h
Johnson & Johnson’s Akeega from AMPLITUDE study shows improved efficacy in patients with HRR-mutated mHSPC
Johnson & Johnson’s Akeega from AMPLITUDE study shows improved efficacy in patients with HRR-mutated mHSPC: Beerse, Belgium Thursday, June 5, 2025, 12:00 Hrs [IST] Johnson & Joh ...
Pharmabiz10h
European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy
European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy: Basel Thursday, June 5, 2025, 09:00 Hrs [IST] Roche announced that the European Commission ...
Pharmabiz9h
Molecular Health & Axxam ink partnership to bolster discovery of innovative targets indrug development
Molecular Health & Axxam ink partnership to bolster discovery of innovative targets indrug development: Milan, Italy Thursday, June 5, 2025, 10:00 Hrs [IST] Axxam S.p.A., a premie ...
Pharmabiz11h
India revises list of stakeholders in anti-dumping probe on NBR from China, EU, Korea & Russia
India revises list of stakeholders in anti-dumping probe on NBR from China, EU, Korea & Russia: Shardul Nautiyal, Mumbai Thursday, June 5, 2025, 08:00 Hrs [IST] In a significant d ...
Pharmabiz8h
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib to treat sickle cell disease
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib to treat sickle cell disease: Paris Thursday, June 5, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ( ...
Pharmabiz10h
India reports 4,302 active Covid-19 cases
With the Covid-19 virus once again emerging as a health concern, India has reported 4,302 active cases, with an increase of 864 cases in the past 24 hours as of June 4, 2025. Most cases are mild and ...